Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A retrospective study of children's perceptions of participation as clinical research subjects in a minimal risk study.

Fogas BS, Oesterheld JR, Shader RI.

J Dev Behav Pediatr. 2001 Aug;22(4):211-6.

PMID:
11530893
2.

[Link between depression and academic self-esteem in gifted children].

Bénony H, Van Der Elst D, Chahraoui K, Bénony C, Marnier JP.

Encephale. 2007 Jan-Feb;33(1):11-20. French.

PMID:
17457290
3.

Creating opportunities for parent empowerment: program effects on the mental health/coping outcomes of critically ill young children and their mothers.

Melnyk BM, Alpert-Gillis L, Feinstein NF, Crean HF, Johnson J, Fairbanks E, Small L, Rubenstein J, Slota M, Corbo-Richert B.

Pediatrics. 2004 Jun;113(6):e597-607.

PMID:
15173543
4.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

5.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
6.
7.

Parents' and children's attitudes toward the enrollment of minors in genetic susceptibility research: implications for informed consent.

Bernhardt BA, Tambor ES, Fraser G, Wissow LS, Geller G.

Am J Med Genet A. 2003 Feb 1;116A(4):315-23.

PMID:
12522783
8.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
9.

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.

Clin Ther. 2009 Aug;31(8):1844-55. doi: 10.1016/j.clinthera.2009.08.002.

PMID:
19808143
10.

Children's views on their involvement in clinical research.

Chappuy H, Doz F, Blanche S, Gentet JC, Tréluyer JM.

Pediatr Blood Cancer. 2008 May;50(5):1043-6.

PMID:
17960770
11.

An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.

Nikles CJ, Mitchell GK, Del Mar CB, Clavarino A, McNairn N.

Pediatrics. 2006 Jun;117(6):2040-6.

PMID:
16740846
12.

Quality assurance questionnaire for professionals fails to improve the quality of informed consent.

Lavori PW, Wilt TJ, Sugarman J.

Clin Trials. 2007;4(6):638-49.

PMID:
18042573
13.
14.
15.

Clinical studies of methylphenidate serum levels in children and adults.

Gualtieri CT, Wargin W, Kanoy R, Patrick K, Shen CD, Youngblood W, Mueller RA, Breese GR.

J Am Acad Child Psychiatry. 1982 Jan;21(1):19-26. No abstract available.

PMID:
7096827
16.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network.

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
17.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
18.

Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.

Berger I, Dor T, Nevo Y, Goldzweig G.

J Child Neurol. 2008 Sep;23(9):1036-42. doi: 10.1177/0883073808317726. Epub 2008 May 16.

PMID:
18487521
19.

Children's self-reports on perceived effects on taking stimulant medication for ADHD.

Thorell LB, Dahlström K.

J Atten Disord. 2009 Mar;12(5):460-8. doi: 10.1177/1087054708320430. Epub 2008 Aug 6.

PMID:
18685139
20.

The quality of parental consent for research with children: a prospective repeated measure self-report survey.

Franck LS, Winter I, Oulton K.

Int J Nurs Stud. 2007 May;44(4):525-33. Epub 2006 May 18.

PMID:
16712850

Supplemental Content

Support Center